These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2177683)

  • 41. 11-hydroxy- 9 -tetrahydrocannabinol: pharmacology, disposition, and metabolism of a major metabolite of marihuana in man.
    Lemberger L; Crabtree RE; Rowe HM
    Science; 1972 Jul; 177(4043):62-4. PubMed ID: 5041775
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cannabinoids in humans. I. Analysis of delta 9-tetrahydrocannabinol and six metabolites in plasma and urine using GC-MS.
    Kemp PM; Abukhalaf IK; Manno JE; Manno BR; Alford DD; Abusada GA
    J Anal Toxicol; 1995 Sep; 19(5):285-91. PubMed ID: 7500614
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CYP3A4 is a major isoform responsible for oxidation of 7-hydroxy-Delta(8)-tetrahydrocannabinol to 7-oxo-delta(8)-tetrahydrocannabinol in human liver microsomes.
    Matsunaga T; Kishi N; Higuchi S; Watanabe K; Ohshima T; Yamamoto I
    Drug Metab Dispos; 2000 Nov; 28(11):1291-6. PubMed ID: 11038155
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proof of active cannabis use comparing 11-hydroxy-∆9-tetrahydrocannabinol with 11-nor-9-carboxy-tetrahydrocannabinol concentrations.
    Franz T; Skopp G; Schwarz G; Musshoff F
    Drug Test Anal; 2018 Oct; 10(10):1573-1578. PubMed ID: 29845743
    [TBL] [Abstract][Full Text] [Related]  

  • 45. delta 1-Tetrahydrocannabinol and 1 alpha, 2 alpha-epoxyhexahydrocannabinol: mutagenicity investigation in the Ames test.
    Glatt H; Ohlsson A; Agurell S; Oesch F
    Mutat Res; 1979 Apr; 66(4):329-35. PubMed ID: 379628
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Microsomal oxygenase catalyzed oxidation of 11-hydroxy-delta 8-tetrahydrocannabinol to 11-oxo-delta 8-tetrahydrocannabinol.
    Watanabe K; Yamamoto I; Oguri K; Yoshimura H
    Biochem Biophys Res Commun; 1979 May; 88(1):178-82. PubMed ID: 36896
    [No Abstract]   [Full Text] [Related]  

  • 47. Intravenous injection in man of 9 -tetrahydrocannabinol and 11-OH- 9 -tetrahydrocannabinol.
    Perez-Reyes M; Timmons MC; Lipton MA; Davis KH; Wall ME
    Science; 1972 Aug; 177(4049):633-5. PubMed ID: 4558903
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Contribution of the metabolite 7-hydroxy-delta1-tetrahydrocannabinol towards the pharmacological activity of delta 1-tetrahydrocannabinol in mice.
    Gill EW; Jones G; Lawrence DK
    Biochem Pharmacol; 1973 Jan; 22(2):175-84. PubMed ID: 4763251
    [No Abstract]   [Full Text] [Related]  

  • 49. Action of delta-9-tetrahydrocannabinol. An approach to the active metabolite hypothesis.
    Hollister LE; Gillespie HK
    Clin Pharmacol Ther; 1975 Dec; 18(6):714-9. PubMed ID: 1204277
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetic factors in sex differences in Delta 9-tetrahydrocannabinol-induced behavioral effects in rats.
    Tseng AH; Harding JW; Craft RM
    Behav Brain Res; 2004 Sep; 154(1):77-83. PubMed ID: 15302113
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Delta9-tetrahydrocannabinol increase plasma testosterone concentrations in mice.
    Dalterio S; Bartke A; Mayfield D
    Science; 1981 Jul; 213(4507):581-3. PubMed ID: 6264607
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vivo and in vitro properties of anti-delta 9-tetrahydrocannabinol antibody.
    Chiarotti M; Giusti GV; Vigevani F
    Drug Alcohol Depend; 1980 Mar; 5(3):231-3. PubMed ID: 6243537
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
    Hayakawa K; Mishima K; Hazekawa M; Sano K; Irie K; Orito K; Egawa T; Kitamura Y; Uchida N; Nishimura R; Egashira N; Iwasaki K; Fujiwara M
    Brain Res; 2008 Jan; 1188():157-64. PubMed ID: 18021759
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacological effects of acute and repeated administration of Delta(9)-tetrahydrocannabinol in adolescent and adult rats.
    Wiley JL; O'connell MM; Tokarz ME; Wright MJ
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1097-105. PubMed ID: 17172531
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential effects of delta-9-tetrahydrocannabinol and its 11-hydroxy metabolite on sodium current in neuroblastoma cells.
    Turkanis SA; Karler R; Partlow LM
    Brain Res; 1991 Sep; 560(1-2):245-50. PubMed ID: 1662110
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rapid tolerance to Delta(9)-tetrahydrocannabinol and cross-tolerance between ethanol and Delta(9)-tetrahydrocannabinol in mice.
    da Silva GE; Morato GS; Takahashi RN
    Eur J Pharmacol; 2001 Nov; 431(2):201-7. PubMed ID: 11728426
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolic disposition of delta 8-tetrahydrocannabinol and its active metabolites, 11-hydroxy-delta 8-tetrahydrocannabinol and 11-oxo-delta 8-tetrahydrocannabinol, in mice.
    Watanabe K; Yamamoto I; Oguri K; Yoshimura H
    Drug Metab Dispos; 1981; 9(3):261-4. PubMed ID: 6113937
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 6 -hydroxy- 1 -tetrahydrocannabinol synthesis and biological activity.
    Ben-Zvi Z; Mechoulam R; Edery H; Porath G
    Science; 1971 Nov; 174(4012):951-2. PubMed ID: 5001309
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Abstinence phenomena of chronic cannabis-addicts prospectively monitored during controlled inpatient detoxification: cannabis withdrawal syndrome and its correlation with delta-9-tetrahydrocannabinol and -metabolites in serum.
    Bonnet U; Specka M; Stratmann U; Ochwadt R; Scherbaum N
    Drug Alcohol Depend; 2014 Oct; 143():189-97. PubMed ID: 25127704
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Δ9-tetrahydrocannabinol and its major metabolite Δ9-tetrahydrocannabinol-11-oic acid as 15-lipoxygenase inhibitors.
    Takeda S; Jiang R; Aramaki H; Imoto M; Toda A; Eyanagi R; Amamoto T; Yamamoto I; Watanabe K
    J Pharm Sci; 2011 Mar; 100(3):1206-11. PubMed ID: 20891010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.